Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis.

Rong G, Zhong R, Lleo A, Leung PS, Bowlus CL, Yang GX, Yang CY, Coppel RL, Ansari AA, Cuebas DA, Worman HJ, Invernizzi P, Gores GJ, Norman G, He XS, Gershwin ME.

Hepatology. 2011 Jul;54(1):196-203. doi: 10.1002/hep.24355.

2.

Apotopes and the biliary specificity of primary biliary cirrhosis.

Lleo A, Selmi C, Invernizzi P, Podda M, Coppel RL, Mackay IR, Gores GJ, Ansari AA, Van de Water J, Gershwin ME.

Hepatology. 2009 Mar;49(3):871-9. doi: 10.1002/hep.22736.

3.

Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.

Moteki S, Leung PS, Coppel RL, Dickson ER, Kaplan MM, Munoz S, Gershwin ME.

Hepatology. 1996 Jul;24(1):97-103.

PMID:
8707289
4.

Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis.

Lleo A, Bowlus CL, Yang GX, Invernizzi P, Podda M, Van de Water J, Ansari AA, Coppel RL, Worman HJ, Gores GJ, Gershwin ME.

Hepatology. 2010 Sep;52(3):987-98. doi: 10.1002/hep.23783.

6.

Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis.

Nishio A, Van de Water J, Leung PS, Joplin R, Neuberger JM, Lake J, Björkland A, Tötterman TH, Peters M, Worman HJ, Ansari AA, Coppel RL, Gershwin ME.

Hepatology. 1997 May;25(5):1085-9.

PMID:
9141421
7.

Characterization of a lipoyl domain-independent B-cell autoepitope on the human branched-chain acyltransferase in primary biliary cirrhosis and overlap syndrome with autoimmune hepatitis.

Csepregi A, Obermayer-Straub P, Kneip S, Kayser A, Loges S, Schmidt E, Nemesánszky E, Szalay F, Manns MP, Strassburg CP.

Clin Dev Immunol. 2003 Jun-Dec;10(2-4):173-81.

8.

Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex.

Moteki S, Leung PS, Dickson ER, Van Thiel DH, Galperin C, Buch T, Alarcon-Segovia D, Kershenobich D, Kawano K, Coppel RL, et al.

Hepatology. 1996 Mar;23(3):436-44.

PMID:
8617422
9.

Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens.

Miyakawa H, Tanaka A, Kikuchi K, Matsushita M, Kitazawa E, Kawaguchi N, Fujikawa H, Gershwin ME.

Hepatology. 2001 Aug;34(2):243-8.

PMID:
11481607
10.

Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis.

Tsuneyama K, Van De Water J, Van Thiel D, Coppel R, Ruebner B, Nakanuma Y, Dickson ER, Gershwin ME.

Hepatology. 1995 Nov;22(5):1440-6.

PMID:
7590661
11.

Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis.

Miyakawa H, Tanaka A, Selmi C, Hosoya N, Mataki N, Kikuchi K, Kato T, Arai J, Goto T, Gershwin ME.

Clin Dev Immunol. 2006 Jun-Dec;13(2-4):289-94.

12.

Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis.

Reynoso-Paz S, Leung PS, Van De Water J, Tanaka A, Munoz S, Bass N, Lindor K, Donald PJ, Coppel RL, Ansari AA, Gershwin ME.

Hepatology. 2000 Jan;31(1):24-9.

PMID:
10613723
13.
14.

Clinical significance of positive immunoblotting but negative immunofluorescence for antimitochondrial antibodies in patients with liver diseases other than primary biliary cirrhosis.

Masuda J, Omagar K, Miyakawa H, Hazama H, Ohba K, Kinoshita H, Matsuo I, Isomoto H, Murata I, Kohno S.

Autoimmunity. 2002 Mar;35(2):135-41.

PMID:
12071436
15.

Clinicopathological study of primary biliary cirrhosis negative for antimitochondrial antibodies.

Nakanuma Y, Harada K, Kaji K, Terasaki S, Tsuneyama K, Moteki S, Van de Water J, Leung PS, Gershwin ME.

Liver. 1997 Dec;17(6):281-7.

PMID:
9455733
16.

Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis.

Mutimer DJ, Fussey SP, Yeaman SJ, Kelly PJ, James OF, Bassendine MF.

Hepatology. 1989 Oct;10(4):403-7.

PMID:
2673968
17.

Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis.

Dubel L, Tanaka A, Leung PS, Van de Water J, Coppel R, Roche T, Johanet C, Motokawa Y, Ansari A, Gershwin ME.

Hepatology. 1999 Apr;29(4):1013-8.

PMID:
10094940
18.

Evaluation of newly developed ELISA using "MESACUP-2 test mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis.

Kadokawa Y, Omagari K, Hazama H, Ohba K, Masuda J, Kinoshita H, Hayashida K, Isomoto H, Mizuta Y, Murase K, Murata I, Kohno S.

Clin Biochem. 2003 May;36(3):203-10.

PMID:
12726929
19.
20.

Immunoreactivity of antimitochondrial autoantibodies in Japanese patients with primary biliary cirrhosis.

Omagari K, Rowley MJ, Jois JA, Feeney SJ, Komatsu K, Maeda T, Onishi S, Yamazaki K, Suzuki K, Galperin C, Mackay IR.

J Gastroenterol. 1996 Feb;31(1):61-8.

PMID:
8808430

Supplemental Content

Support Center